Responses
Therapeutics
Randomised controlled trial
Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone
Compose a Response to This Article
Other responses
No responses have been published for this article.